Cancer News and Research

Latest Cancer News and Research

Cancer cells produce small amount of collagen that impacts tumor microbiome and immunity

Cancer cells produce small amounts of their own form of collagen, creating a unique extracellular matrix that affects the tumor microbiome and protects against immune responses, according to a new study by researchers at The University of Texas MD Anderson Cancer Center.

21 Jul 2022

Immuno-infrared sensor identifies Alzheimer's disease in the blood up to 17 years in advance

A sensor identifies misfolded protein biomarkers in the blood. This offers a chance to detect Alzheimer's disease before any symptoms occur. Researchers intend to bring it to market maturity.

21 Jul 2022

New study to investigate focused ultrasound's role in addressing neurofibromatosis type 2

The Focused Ultrasound Foundation and the Children's Tumor Foundation (CTF) have established a partnership to advance innovative, noninvasive treatments in pediatrics.

21 Jul 2022

FDA clears IND application for MD Anderson-sponsored Phase I clinical study of OBX-115 therapy

The University of Texas MD Anderson Cancer Center and Obsidian Therapeutics, Inc. today announced Food and Drug Administration (FDA) clearance of an Investigational New Drug (IND) application for an MD Anderson-sponsored Phase I clinical study of OBX-115, Obsidian's lead engineered tumor infiltrating lymphocyte (TIL) therapy candidate.

21 Jul 2022

Cigarette smokers who try to quit often become dual nicotine users

Researchers at Washington University School of Medicine in St. Louis have found that as people who smoke cigarettes attempt to quit, some move to e-cigarettes, but such people often become dual nicotine users, smoking traditional cigarettes and vaping e-cigarettes.

21 Jul 2022

COVID vaccines induce memory B and T cells in primary antibody deficient patients

The SARS-CoV-2-specific B- and T-cell response post-COVID-19 primary and booster vaccination in primary antibody deficient patients.

20 Jul 2022

Research highlights the impact of social determinants of health on hypertension control

A research article published this month in the Mayo Clinic Proceedings highlights the significant impact of social determinants of health on patients' ability to sustain control of hypertension.

20 Jul 2022

International Agency for Research on Cancer classifies firefighting as carcinogenic

The International Agency for Research on Cancer recently classified occupational exposure as a firefighter as carcinogenic, changing the previous classification of possibly carcinogenic.

20 Jul 2022

Charged nanoparticles combined with a vaccine effective in eliminating melanoma tumors in mice

Cancers in humans have all sorts of ways to survive and thrive: Cells and tumors alike engage in devious means to deflect, deceive, and evade detection by our bodies’ immune systems.

20 Jul 2022

Scientists find a promising new combination therapy for certain types of lung tumors

Scientists at the Francis Crick Institute have found that using immunotherapy alongside a drug that blocks a common gene mutation in lung cancer could be a promising new combination therapy for certain types of lung tumors.

20 Jul 2022

New evidence-based training program to improve serious illness conversations for cancer patients

Patients with advanced cancer want and need to partner with their care team to make treatment decisions that reflect their own values and align with what matters most.

20 Jul 2022

Hollings researcher awarded grant to continue research into mechanisms behind medulloblastoma relapse

When MUSC Hollings Cancer Center researcher Jezabel R. Blanco, Ph.D., began studying neurosciences, first as a graduate student and later as a postdoctoral fellow, her research was focused on understanding the mechanisms underlying brain disease, both in the context of neurodegeneration and cancer, but mostly from a basic research angle.

20 Jul 2022

Nanotherapeutic compound may help treat inflammation, brain injury in patients with severe COVID-19

An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chances of death, according to a new study from UTHealth Houston and other institutions.

20 Jul 2022

Novel blood test offers unprecedented insight into a patient's cancer make-up

Researchers at the Vancouver Prostate Centre have developed a new blood test that provides unprecedented insight into a patient's cancer make-up, potentially allowing doctors to better select treatment options that will improve patient outcomes.

20 Jul 2022

Combinations of broadly neutralizing antibodies may be a more effective approach to treat HIV

Carefully designed cocktails of broadly neutralizing antibodies (bNAbs) could help treat HIV while minimizing the risk of the virus escaping treatment, suggests a study published today in eLife.

20 Jul 2022

Modifying lifestyle risk factors can offset a genetic risk of stroke, study shows

People who are genetically at higher risk for stroke can lower that risk by as much as 43% by adopting a healthy cardiovascular lifestyle, according to new research led by UTHealth Houston, which was published today in the Journal of the American Heart Association.

20 Jul 2022

Cancer News and Research

Latest Cancer News and Research

Cancer cells produce small amount of collagen that impacts tumor microbiome and immunity

Immuno-infrared sensor identifies Alzheimer's disease in the blood up to 17 years in advance

New study to investigate focused ultrasound's role in addressing neurofibromatosis type 2

FDA clears IND application for MD Anderson-sponsored Phase I clinical study of OBX-115 therapy

Cigarette smokers who try to quit often become dual nicotine users

COVID vaccines induce memory B and T cells in primary antibody deficient patients

Research highlights the impact of social determinants of health on hypertension control

International Agency for Research on Cancer classifies firefighting as carcinogenic

Charged nanoparticles combined with a vaccine effective in eliminating melanoma tumors in mice

Scientists find a promising new combination therapy for certain types of lung tumors

New evidence-based training program to improve serious illness conversations for cancer patients

Hollings researcher awarded grant to continue research into mechanisms behind medulloblastoma relapse

Nanotherapeutic compound may help treat inflammation, brain injury in patients with severe COVID-19

Novel blood test offers unprecedented insight into a patient's cancer make-up

Combinations of broadly neutralizing antibodies may be a more effective approach to treat HIV

Modifying lifestyle risk factors can offset a genetic risk of stroke, study shows

Omicron-specific mRNA vaccine provides superior immune protection against two viral subvariants

Machine learning models help forecast immunotherapy response from gut microbiomes

Genes underlying cigarette smoking linked to the perception of pain and response to food

Scientists find new evidence against using BET inhibitors to treat COVID-19

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in